The investment represents another step in BAT’s exploration beyond tobacco and nicotine products.Read More
Charlotte’s Web will issue 6,119,121 shares of its common stock to the sports organization.Read More
Companies are accused of illegally selling unapproved animal drugs containing cannabidiol.Read More
It's the first time the FDA has issued warning letters for marketing products containing delta-8 THC. Read More
Turning Point Brands is embracing next-gen tobacco and alternative products by taking calculated risks.Read More
The FDA told Charlotte’s Web that its cannabidiol product cannot be sold as a dietary supplement.Read More
The lineup features five product formats that allow for consumers a variety of CBD consumption methods.Read More
The cannabidiol (CBD) market is preparing for industry regulations from the U.S. FDA.Read More
As a ‘hero ingredient’, CBD has the potential to enhance multiple categories and formats.Read More
The cost of entry in the CBD space will become increasingly tougher once FDA begins regulations.Read More